Michael L. Maitland

University Of Chicago

$2,225,073

Attributed

$4,992,648

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2007–20

$2M$1.5M$1M$500K$0

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$4,992,648 · 5

By mechanism

R01$2,882,112 · 1

UM1$986,528 · 1

K23$649,215 · 1

T32$410,223 · 1

M01$64,570 · 1

Top collaborators

Most similar at University Of Chicago

Same institution · by research overlap

Mark J Ratain$26,736,475
M Eileen Dolan$15,055,139
Olufunmilayo I Olopade$31,360,913
Peter Hugh O'Donnell$8,826,322
Michelle M Le Beau$39,023,275

Others in their field

Top investigators on “Clinical Trials”

Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
Sonia M Thomas · Research Triangle Institute$700,865,642
David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
Bambra Strokes · Ppd Development Lp$526,656,217
Judith S. Currier · University Of California Los Angeles$504,273,077

Research focus

Clinical TrialsResearch PersonnelData SetUniversitiesBaseMalignant NeoplasmsDesignDrug DevelopmentChicagoCancer TherapySuccessProgramsPharmaceutical PreparationsLeadClinical PharmacologyMeasurementPhysiciansOncologyAntineoplastic AgentsRenal CarcinomaImageClinical Trials DesignRenal Cell CarcinomaPredictive Value